Expected earnings - Cytodyn Inc
Source: US Earnings Reports
Cytodyn Inc (CYDY) is expected to report for Q1 2026
Cytodyn Inc
NASDAQ: CYDY
CYDY Trading
-3.73% G/L:
$0.232 Last:
725,325 Volume:
$0.233 Open:
CYDY Latest News
March 05, 2026 08:30:00 am
CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab
February 20, 2026 08:30:00 am
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
January 27, 2026 08:30:00 am
CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer
CYDY Stock Data
$314,422,763
1,220,108,670
0.08%
29
N/A
Biotechnology & Life Sciences
Healthcare
US
Vancouver
